Diagnosis of meningococcal meningitis, although aided occasionally by Gram stain results, is usually based on clinical presentation. Rapid test such as Gram stain, counterimmunoelectrophoresis, latex particle agglutination, coagglutination, and enzyme-linked immunoassay have been used with limited success for rapid detection of bacterial antigens (1, 2, (4) (5) (6) (7) (8) (9) . The incidence and severity of meningococcal meningitis have prompted the development of rapid diagnostic methods. For this purpose, we evaluated the Phadebact and Bactigen reagents, designed specifically to guide therapy by rapid detection of Neisseria meningitidis in cerebrospinal fluids (CSF).
The Phadebact coagglutination test (Pharmacia Diagnostics, Piscataway, N.J.) and the Bactigen latex agglutination mailed to the State Laboratory of Hygiene where they were stored at -60°C until used. N. meningitidis was cultured from 18 CSF specimens, and then the bacteria were grouped with reference sera obtained from the Centers for Disease Control (Atlanta, Ga.). They included 11 organisms from group B, 4 from group C, and 1 from group W135. The group of the remaining two meningococcal isolates was not determined. Haemophilus influenzae was isolated from 24 CSF specimens, and 15 of these isolates were type b. An additional culture-negative specimen was positive for H. influenzae type b by counterimmunoelectrophoresis. Six CSF samples were from patients with Streptococcus pneumoniae meningitis. Two additional specimens were negative for growth but were positive for S. pneumoniae by counterim- Health Service, Bethesda, Md., and diluted in saline. All antigens were stored at -60°C until used. The sensitivity (3; true-positive rate) of the Phadebact test for N. meningitidis was 28% when the reactions were read after 1 min (data not shown) and 78% after 4 min ( Table 2 ). All reactions, however, were weak (11 were 1+ and 3 were 2+). When the data were analyzed according to serogroups, the sensitivities after 1 min were 36% for group B (4 of 11), 0% for group C (0 of 4), 0% for group W135 (0 of 1), and 50%o (1 of 2) for those not grouped. These values increased to 73% (8 of 11), 75% (3 of 4), 100% (1 of 1), and 100% (2 of 2), respectively, after 4 min, with an average sensitivity of 78%. The sensitivity of the Bactigen test was also 78%. The Bactigen test detected 82% (9 of 11) of group B and 67% (2 of 3) of group C. However, Bactigen reactions were easier to interpret (.-3+ reactions), and there were no cross-reactions.
The specificity (3) of the Phadebact test was 88% (Table  2) . Of 25 specimens, 9 (36%) that were positive by culture or counterimmunoelectrophoresis for H. influenzae gave a 1+ reaction with the Phadebact reagent for detection of N. meningitidis within 2 to 4 min. Specificity increased to 99% when these CSF specimens were examined concurrently with the Phadebact H. influenzae reagent, since homologous reactions were stronger (4+). No false-positive reactions were detected in CSF specimens positive for S. penumoniae or the 25 control specimens. In addition, no false positives were detected with CSF containing other pathogens. The specificity of the Bactigen test was 100%, although false-positive reactions were not determined in CSF containing S. pneumoniae and H. influenzae.
The sensitivity of the Phadebact test for detecting purified antigens A and C was 103 to 102 ng/ml (Table 3) . These reactions were weak (c +2) and occurred only within a narrow range of antigen concentrations. The Phadebact test also failed to agglutinate all concentrations of purified group B antigen. In contrast, the Bactigen test detected a wide range of purified antigens with a strong reaction. Only the Bactigen group B reagent failed to detect antigen below 1 ng/ml. When boiled suspensions of individual cultures of meningococcal groups A, B, and C were used to determine sensitivity, the Bactigen test detected 104 organisms per ml with reagents A and B and 105 organisms per ml with reagent C. The Phadebact test detected 106 group A, 108 group B, and 107 group C organisms per ml. These results show that the Bactigen test was ca. 10,000-fold more sensitive than the Phadebact test.
Although the sensitivity of the Phadebact test was 78%, most reactions were weak (1+) and open to interpretation. Similar results were obtained by Tilton et al. (7) . Many of these reactions would be overlooked in laboratories where few positive CSF specimens are obtained. The Phadebact test also produced false-positive reactions in CSF containing H. influenzae. Therefore, the Bactigen test has advantages since it yielded strong reactions and was more sensitive for detecting small quantities of purified antigens and whole 
